{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:16:05Z","timestamp":1783426565805,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":138,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2026.102437","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T06:55:30Z","timestamp":1779519330000},"page":"102437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A case of severe Legionella pneumonia treated with omadacycline and nemonoxacin"],"prefix":"10.1016","volume":"62","author":[{"given":"Tingrui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13613-024-01252-y","article-title":"Severe legionnaires' disease","volume":"14","author":"Rello","year":"2024","journal-title":"Ann. Intensive Care"},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib2","first-page":"43","article-title":"Thoracic imaging features of legionnaire's disease","volume":"31","author":"Mittal","year":"2017","journal-title":"Infect. Dis. Clin."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102437_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40121-022-00635-7","article-title":"Legionnaires' disease: update on diagnosis and treatment","volume":"11","author":"Viasus","year":"2022","journal-title":"Infect. Dis. Ther."},{"issue":"11","key":"10.1016\/j.rmcr.2026.102437_bib4","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/cid\/ciaa441","article-title":"Are fluoroquinolones or macrolides better for treating legionella pneumonia? A systematic review and meta-analysis","volume":"72","author":"Jasper","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.rmcr.2026.102437_bib5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/jac\/dkz081","article-title":"Susceptibility of legionella pneumophila to antimicrobial agents and the presence of the efflux pump lpeab","volume":"74","author":"Natas","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.rmcr.2026.102437_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/jac\/dkz081","article-title":"Susceptibility of legionella pneumophila to antimicrobial agents and the presence of the efflux pump lpeab","volume":"74","author":"Nat S","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.rmcr.2026.102437_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ebiom.2015.07.018","article-title":"Hidden selection of bacterial resistance to fluoroquinolones in vivo: the case of legionella pneumophila and humans","volume":"2","author":"Shadoud","year":"2015","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.rmcr.2026.102437_bib8","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the american thoracic society and infectious diseases society of america","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmcr.2026.102437_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2500170","article-title":"Community-acquired pneumonia in adults","volume":"4","author":"Bai","year":"2025","journal-title":"NEJM Evid."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14715\/cmb\/2022.69.1.13","article-title":"The formation and drug resistance mechanism of biofilm for streptococcus pneumoniae infection in severe respiratory patients","volume":"69","author":"Sun","year":"2023","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand, France)"},{"key":"10.1016\/j.rmcr.2026.102437_bib11","article-title":"Molecular characterization of penicillin-binding protein2x, 2b and 1a of streptococcus pneumoniae causing invasive pneumococcal diseases in China: a multicenter study","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rmcr.2026.102437_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102589","article-title":"Effectiveness and safety of tetracyclines and quinolones in people with mycoplasma pneumonia: a systematic review and network meta-analysis","volume":"71","author":"Cai","year":"2024","journal-title":"Eclinicalmedicine"},{"key":"10.1016\/j.rmcr.2026.102437_bib13","article-title":"Severe problem of macrolides resistance to common pathogens in China","volume":"13","author":"Li","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102437_bib14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/AAC.01197-09","article-title":"Comparative in vitro activities of nemonoxacin (tg-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates","volume":"54","author":"Lauderdale","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.rmcr.2026.102437_bib15","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1128\/AAC.00078-09","article-title":"In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates","volume":"53","author":"Adam","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.rmcr.2026.102437_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107235","article-title":"A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. Levofloxacin for community-acquired pneumonia in adult patients","volume":"64","author":"Li","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00134-025-08252-x","article-title":"Severe community-acquired pneumonia: current concepts and controversies","volume":"52","author":"Dequin","year":"2026","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.rmcr.2026.102437_bib18","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2147\/IDR.S171352","article-title":"Omadacycline: a novel aminomethylcycline","volume":"12","author":"Burgos","year":"2019","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01784-16","article-title":"Pharmacokinetics, distribution, metabolism, and excretion of omadacycline following a single intravenous or oral dose of 14c-omadacycline in rats","volume":"61","author":"Lin","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmcr.2026.102437_bib20","article-title":"Efficacy of omadacycline in the treatment of legionella pneumonia: a case report","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.rmcr.2026.102437_bib21","article-title":"Omadacycline for the treatment of patients with legionella pneumophila pneumonia after experiencing liver dysfunction: case series","volume":"15","author":"Zhu","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rmcr.2026.102437_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102654","article-title":"Omadacycline use in a traveler with severe legionella pneumonia","volume":"56","author":"Wang","year":"2023","journal-title":"Trav. Med. Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1378\/chest.91.1.57","article-title":"Pulmonary fibrosis following pneumonia due to acute legionnaires' disease. Clinical, ultrastructural, and immunofluorescent study","volume":"91","author":"Chastre","year":"1987","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmcr.2026.102437_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10156-010-0205-y","article-title":"Organizing pneumonia pattern in the follow-up ct of legionella-infected patients","volume":"17","author":"Haroon","year":"2011","journal-title":"J. Infect. Chemother."},{"issue":"2","key":"10.1016\/j.rmcr.2026.102437_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00052-09","article-title":"Molecular pathogenesis of infections caused by legionella pneumophila","volume":"23","author":"Newton","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"21","key":"10.1016\/j.rmcr.2026.102437_bib26","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12877-025-05852-6","article-title":"Efficacy and safety of glucocorticoids therapy of severe community-acquired pneumonia in older adults: a systematic review and meta-analysis","volume":"25","author":"Ali","year":"2025","journal-title":"BMC Geriatr."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s40001-025-02487-6","article-title":"Glucocorticoids can reduce mortality in patients with severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Gu","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.rmcr.2026.102437_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1457469","article-title":"The effect and safety of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis of randomized controlled trials","volume":"11","author":"Chen","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.rmcr.2026.102437_bib30","article-title":"Association between various types of corticosteroids and mortality for severe community-acquired pneumonia in adults: a systematic review and network meta-analysis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102437_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chest.2022.08.2229","article-title":"Effect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: a systematic review, meta-analysis, and meta-regression of randomized control trials","volume":"163","author":"Saleem","year":"2023","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmcr.2026.102437_bib32","first-page":"24","article-title":"Diagnosis and management of community-acquired pneumonia: an official american thoracic society clinical practice guideline","volume":"212","author":"Jones","year":"2026","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmcr.2026.102437_bib33","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmcr.2026.102437_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/CCM.0000000000006171","article-title":"Executive summary: guidelines on use of corticosteroids in critically ill patients with sepsis, acute respiratory distress syndrome, and community-acquired pneumonia focused update 2024","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmcr.2026.102437_bib35","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1093\/rheumatology\/keac209","article-title":"Autoimmune disease and covid-19: a multicentre observational study in the United Kingdom","volume":"61","author":"Arachchillage","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmcr.2026.102437_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2020.04.027","article-title":"Hyperinflammation and derangement of renin-angiotensin-aldosterone system in covid-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis","volume":"507","author":"Henry","year":"2020","journal-title":"Clinica chimica acta; Int. J. Clinic. Chem."},{"issue":"570","key":"10.1016\/j.rmcr.2026.102437_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with covid-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:33:29Z","timestamp":1783424009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007126000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":37,"alternative-id":["S2213007126000742"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102437","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of severe Legionella pneumonia treated with omadacycline and nemonoxacin","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102437"}}